Status:
UNKNOWN
Minimally Invasive Rheumatic Mitral Valve Surgery
Lead Sponsor:
Assiut University
Conditions:
Rheumatic Mitral Valve Disease
Eligibility:
All Genders
10-90 years
Brief Summary
Early outcome of minimally invasive rheumatic mitral valve surgery through periareolar versus submamary approach
Detailed Description
Rheumatic heart valve disease (RHVD) is a post-infectious sequel of acute rheumatic fever resulting from an abnormal immune response to a streptococcal pharyngitis that triggers valvular damage. RHVD ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of rheumatic mitral valve
- Patient undergoing minimal invasive rheumatic mitral valve surgery
- Patient is willing to comply with all follow-up visits.
- Willing and able to provide written informed consent and comply with study requirements
Exclusion
- Ischemic heart disease
- Patients need another valve replacement
- Redo mitral valve replacement
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05270590
Start Date
March 1 2022
End Date
January 1 2026
Last Update
March 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.